Dr. Usman's Cardiology Notes

Left Anterior Fascicular Block (LAFB) Left Anterior Fascicular Block (LAFB), also called left anterior hemiblock, is a conduction abnormality involving the anterior fascicle of the left bundle branch. It is one of the most common intraventricular conduction disturbances seen on ECG. LAFB alters the normal sequence of ventricular depolarization and produces a characteristic pattern of left axis deviation on the electrocardiogram. Recognition of LAFB is important because it may occur in otherwise healthy individuals, but it can also be associated with structural heart disease such as ischemic heart disease, cardiomyopathy, or degenerative conduction system disease. --- Anatomy and Pathophysiology The left bundle branch divides into two main fascicles: 1. Left anterior fascicle 2. Left posterior fascicle The left anterior fascicle is thin and long, making it more vulnerable to damage from ischemia, fibrosis, or degeneration. In LAFB, conduction through the anterior fascicle is blocked. As...

Valvular Heart Disease Modifies Diastolic Assessment Parameters Diastolic function assessment by echocardiography is an essential component of cardiovascular evaluation, particularly in patients with dyspnea, heart failure, or structural heart disease. Standard diastolic indices such as E/A ratio, E/e′ ratio, left atrial volume, and tricuspid regurgitation velocity are widely used to estimate left ventricular filling pressures. However, the presence of valvular heart disease significantly alters these parameters and may lead to misinterpretation if standard algorithms are applied without modification. Understanding how specific valvular lesions affect diastolic indices is therefore crucial for accurate hemodynamic interpretation. --- Mitral Annular Calcification (MAC) Mitral annular calcification is a degenerative process characterized by calcium deposition at the mitral annulus. It is commonly seen in elderly patients and those with chronic kidney disease, hypertension, and diabetes. ...

  When a Patient Dies in the Cath Lab.  Most people never see what happens after a patient dies in the cath lab. The room eventually gets cleaned. The equipment is reset. Another case may already be waiting. But for the team who was there, the moment does not just disappear. Cath lab physicians, nurses, and technologists are trained to stay focused and move forward quickly. Yet the emotional weight of losing a patient can stay with the people in that room long after the procedure ends. This side of cath lab work is rarely discussed, but it is part of the reality of high-acuity cardiovascular care. When a patient dies in the cath lab, what does real support for the team look like in your lab? Debriefing? Peer support? Or simply moving on to the next case?

  Role of Mavacamten in Hypertrophic Cardiomyopathy (HCM) Mavacamten is a first-in-class cardiac myosin inhibitor used in the treatment of symptomatic obstructive hypertrophic cardiomyopathy (HCM). It targets the underlying pathophysiology of the disease rather than only treating symptoms. --- Mechanism of Action In HCM, excessive interaction between actin and myosin leads to hypercontractility and impaired relaxation of the myocardium. Mavacamten works by: • Inhibiting cardiac myosin ATPase activity • Reducing actin–myosin cross-bridge formation • Decreasing hypercontractility of the left ventricle This leads to: • Reduction in LV outflow tract (LVOT) obstruction • Improvement in diastolic relaxation • Decrease in myocardial energy consumption --- Clinical Effects Mavacamten has been shown to: • Reduce LVOT gradient • Improve NYHA functional class • Improve exercise capacity (peak VO₂) • Reduce symptoms such as dyspnea and chest pain --- Key Clinical Trial The EXPLORER‑HCM trial d...

ICD Indications in Hypertrophic Cardiomyopathy (HCM) Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac disorders and an important cause of sudden cardiac death (SCD), particularly in young individuals and athletes. Implantable cardioverter-defibrillator (ICD) therapy is the most effective strategy for preventing SCD in these patients. Current recommendations are mainly derived from the American Heart Association and American College of Cardiology guidelines. --- Purpose of ICD in HCM The primary role of an ICD in HCM is prevention of sudden cardiac death due to malignant ventricular arrhythmias such as ventricular tachycardia or ventricular fibrillation. ICD therapy is used in two situations: • Secondary prevention • Primary prevention (based on risk stratification) --- 1. Secondary Prevention ICD ICD implantation is strongly recommended (Class I indication) in HCM patients with any of the following: • Prior cardiac arrest due to ventricular fibrillation • S...

  PAINESD Score for Assessing Hemodynamic Instability Risk in Ventricular Tachycardia Ablation Introduction Catheter ablation for ventricular tachycardia (VT) can precipitate acute hemodynamic decompensation (AHD), particularly in patients with severe structural heart disease. To predict this risk before the procedure, the PAINESD score was developed. It is a validated clinical risk score used to estimate the likelihood of periprocedural hemodynamic instability during VT ablation and helps guide decisions regarding mechanical circulatory support (MCS) such as Impella or ECMO. --- Components of the PAINESD Score PAINESD is an acronym derived from the key predictors of hemodynamic compromise. Parameter Points P – Pulmonary disease (COPD) 5 A – Age > 60 years 3 I – Ischemic cardiomyopathy 6 N – NYHA Class III or IV heart failure 6 E – Ejection Fraction < 25% 3 S – VT Storm 5 D – Diabetes Mellitus 3 Maximum possible score: 31 points --- Risk Stratification PAINESD Score Risk of A...

  Triad of Hypothyroidism  Hypothyroidism is a common endocrine disorder characterized by reduced thyroid hormone production, leading to a generalized slowing of metabolic processes. Although the clinical presentation can be broad and nonspecific, a classic and easily remembered clinical combination is the Triad of Hypothyroidism, which includes weight gain, fatigue, and cold intolerance. Recognizing this triad can help clinicians suspect hypothyroidism early and prompt appropriate laboratory evaluation. --- Weight Gain Weight gain in hypothyroidism is primarily due to reduced basal metabolic rate and accumulation of interstitial fluid rather than true fat deposition alone. Thyroid hormones normally regulate energy expenditure and lipid metabolism. When hormone levels fall, metabolic activity decreases, resulting in gradual weight gain. Patients often report difficulty losing weight despite unchanged diet or activity levels. --- Fatigue Fatigue is one of the most common presen...